|
End-of-day quote
Shenzhen S.E.
06/11/2026
|
5-day change | 1st Jan Change | ||
| 7.830 CNY | -2.13% |
|
+2.09% | -25.99% |
| Market Cap | 3.77B 565M 507M 463M 423M 796M 53.09B 821M 5.58B 2.22B 28.33B 2.12B 2.07B 89.42B | P/E 2024 |
-50.1x | P/E 2025 | 353x |
|---|---|---|---|---|---|
| Enterprise Value | 2.23B 334M 299M 274M 250M 471M 31.38B 485M 3.3B 1.32B 16.74B 1.25B 1.23B 52.86B | EV / Sales 2024 |
4.33x | EV / Sales 2025 | 8.78x |
| Free-Float |
42.39% | Yield 2024 * |
-
| Yield 2025 | 2.84% |
| 1 day | -2.13% | ||
| 1 week | +2.09% | ||
| Current month | +2.09% | ||
| 1 month | -9.48% | ||
| 3 months | -18.69% | ||
| 6 months | -27.37% | ||
| Current year | -25.99% |
| 1 week | 7.5 |  | 8.01 |
| 1 month | 7.32 | | 8.68 |
| Current year | 7.32 | | 12.9 |
| 1 year | 7.32 | | 13.8 |
| 3 years | 5.73 | | 17.49 |
| 5 years | 5.73 | | 18.75 |
| 10 years | 5.73 | | 28.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Biao Ma
CEO | Chief Executive Officer | 62 | 05/07/2001 |
Dong Na Liang
DFI | Director of Finance/CFO | 45 | 26/01/2024 |
Li Ma
DFI | Director of Finance/CFO | 57 | 15/12/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
Xue Feng Wang
BRD | Director/Board Member | 48 | 01/03/2009 |
Biao Ma
CHM | Chairman | 62 | 05/07/2001 |
Li Ma
BRD | Director/Board Member | 57 | 01/10/2005 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.13% | +2.09% | -34.37% | -31.32% | 565M | |
| -0.79% | -4.48% | +46.48% | +125.69% | 1,206B | |
| +1.43% | +1.11% | +48.05% | +83.05% | 665B | |
| +1.07% | -1.21% | +32.92% | +104.92% | 515B | |
| -0.36% | -3.25% | +45.42% | +65.10% | 381B | |
| -0.14% | -1.87% | +70.06% | +41.09% | 362B | |
| -0.78% | -0.52% | +30.47% | +58.09% | 307B | |
| -0.80% | -0.21% | +7.98% | +36.17% | 289B | |
| +0.03% | -1.20% | +43.79% | +69.83% | 249B | |
| -0.41% | -2.22% | +40.43% | +107.03% | 207B | |
| Average | -0.29% | -1.22% | +33.12% | +65.97% | 418.03B | |
| Weighted average by Cap. | -0.04% | -1.96% | +42.70% | +88.10% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 416M 62.36M 55.93M 51.12M 46.66M 87.92M 5.86B 90.69M 616M 246M 3.13B 234M 229M 9.87B | 405M 60.6M 54.35M 49.67M 45.35M 85.43M 5.7B 88.13M 599M 239M 3.04B 227M 223M 9.6B |
| Net income | -68.85M -10.31M -9.25M -8.45M -7.71M -14.53M -969M -14.99M -102M -40.62M -517M -38.7M -37.87M -1.63B | 14.57M 2.18M 1.96M 1.79M 1.63M 3.08M 205M 3.17M 21.56M 8.6M 109M 8.19M 8.01M 345M |
| Net Debt | -1.57B -235M -211M -193M -176M -332M -22.12B -342M -2.33B -927M -11.8B -883M -864M -37.26B | -1.54B -231M -207M -189M -173M -326M -21.71B -336M -2.28B -910M -11.58B -867M -848M -36.57B |
Employees
489
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/11/26 | CN¥7.830 | -2.12% | 3,200,200 |
| 05/11/26 | CN¥8.000 | +2.17% | 4,041,200 |
| 04/11/26 | CN¥7.830 | +1.42% | 4,711,993 |
| 03/11/26 | CN¥7.720 | +0.26% | 3,600,730 |
| 02/11/26 | CN¥7.700 | +0.39% | 5,157,602 |
- Stock Market
- Stocks
- 300485 Stock
Select your edition
All financial news and data tailored to specific country editions
